Jenny Moell is currently an Associate Principal Specialist in Clinical Study Management at AstraZeneca, where they oversee the EU CT Regulation Part II. They previously worked as an In-house CRA and Clinical Study Associate at ICON plc, which merged with PRA Health Sciences, and served as a Clinical Trial Assistant at IQVIA supporting Amgen. Jenny also held positions as a Biomedical Analyst at Region Östergötland and a Medical Engineer at Karolinska Universitetssjukhuset. They earned a Bachelor’s degree in Biomedical Sciences from Linköpings universitet and a Master's degree in the same field from Uppsala universitet, where they also completed a course in Clinical Drug Development. Their passions lie in clinical drug development, particularly in neurology, cancer, and orphan drugs.
This person is not in the org chart
This person is not in any teams
This person is not in any offices